Benzodiazepines may have protective effects against Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 1, 1998, Pages 14-17

  Fastbom, Johan ^a   Forsell, Y ^a   Winblad, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer disease; Benzodiazepines; Dementia; Protection

Indexed keywords

BENZODIAZEPINE DERIVATIVE; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; DRUG USE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; SEX RATIO;

EID: 0032459161     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199803000-00002     Document Type: Article

References (14)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed., revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987:97-163.
2. Breitner JCS, Welsh KA, Helms MJ, et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16:523-30.
3. Breteler MMB, Claus JJ, VanDuijn CM, Launer O, Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev 1992;14:59-82.
4. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
5. Danysz W, Parsons CG, Bresink I, Quack G. Glutamate in CNS disorders. Drugs News Perspect 1995;8:261-77.
6. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
7. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology 1991;41:1886-92.
8. Fratiglioni L, Viitanen M, Bäckman L, Sandman P-O, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992;11(Suppl 1):29-36.
9. Fratiglioni L, Viitanen M, Von Strauss E, et al. Late-onset Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. In: Iqbal K, Winblad B, NishimuraT, et al., eds. Alzheimer's disease: biology, diagnosis and therapeutics. Chichester: John Wiley & Sons, 1997:49-53.
10. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7.
11. Müller WE, Mutschler E, Riederer P. Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia. Pharmacopsychiatry 1995;28:113-24.
12. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-61.
13. Sternau LL, Lust D, Ricci AJ, Ratcheson R. Role for γ-aminoburyric acid in selective vulnerability in gerbils. Stroke 1989;20:281-7.
14. Tune LE, Bylsma FW. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatr 1991;3:397-408.